Tuesday's Analysts' Upgrades, Downgrades

Change in Ratings

Barr Pharma

(BRL)

upgraded at Cowen from neutral to outperform. Risks are factored into the stock, and the company should soon enter a solid U.S. product cycle.

ICF

(ICFI) - Get Report

upgraded at UBS to buy rating from neutral. Price target and fiscal year 2008 EPS estimates hold at $22 and $1.47.

Sirius Satellite

(SIRI) - Get Report

upgraded at Merrill to neutral. Company showed solid subscriber growth in the first quarter, and negative sentiment toward the stock is likely passed its peak.

Stock Comments/EPS Changes

Fluor

(FLR) - Get Report

numbers raised at UBS. Price target rockets to $215 from $165 and fiscal year 2008 EPS jumps to $6.40 from $5.50. Reiterates buy rating.

Fluor price target raised at Goldman to $175 from $155 following better-than-expected first-quarter earnings and raised 2008 guidance. See positive outlook for endmarkets. Maintained neutral rating.

Moody's

(MCO) - Get Report

initiated at Jefferies with buy rating. Price target starts at $47 with 2008 EPS estimates set at $1.95.

McGraw-Hill

(MHP)

initiated at Jefferies with buy rating. Price target starts at $49 with 2008 EPS estimates set at $2.80.

Research In Motion

(RIMM)

target raised at Goldman to $148 from $145 based on increased confidence in BlackBerry ecosystem and ability to gain market share in smartphone market. Note additional 3G/WiFi enabled devices shipping in 2008 and extending product cycle.

Sprint Nextel

(S) - Get Report

numbers raised at UBS. Price target lifts to $10 from $7.25 and fiscal year 2009 EPS goes positive to 14 cents from loss of 18 cents. Reiterates neutral rating.

This article was written by a staff member of TheStreet.com Ratings.